970 related articles for article (PubMed ID: 17561143)
1. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems.
Parsons JK
J Urol; 2007 Aug; 178(2):395-401. PubMed ID: 17561143
[TBL] [Abstract][Full Text] [Related]
2. Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions.
Parsons JK; Sarma AV; McVary K; Wei JT
J Urol; 2009 Dec; 182(6 Suppl):S27-31. PubMed ID: 19846130
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
4. Diabetes and benign prostatic hyperplasia/lower urinary tract symptoms--what do we know?
Sarma AV; Parsons JK; McVary K; Wei JT
J Urol; 2009 Dec; 182(6 Suppl):S32-7. PubMed ID: 19846144
[TBL] [Abstract][Full Text] [Related]
5. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
[TBL] [Abstract][Full Text] [Related]
6. Incidence rates and risk factors for acute urinary retention: the health professionals followup study.
Meigs JB; Barry MJ; Giovannucci E; Rimm EB; Stampfer MJ; Kawachi I
J Urol; 1999 Aug; 162(2):376-82. PubMed ID: 10411042
[TBL] [Abstract][Full Text] [Related]
7. Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions.
Parsons JK; Sarma AV; McVary K; Wei JT
J Urol; 2013 Jan; 189(1 Suppl):S102-6. PubMed ID: 23234610
[TBL] [Abstract][Full Text] [Related]
8. Alcohol consumption is associated with a decreased risk of benign prostatic hyperplasia.
Parsons JK; Im R
J Urol; 2009 Oct; 182(4):1463-8. PubMed ID: 19683313
[TBL] [Abstract][Full Text] [Related]
9. Prevention of benign prostatic hyperplasia disease.
Marks LS; Roehrborn CG; Andriole GL
J Urol; 2006 Oct; 176(4 Pt 1):1299-306. PubMed ID: 16952616
[TBL] [Abstract][Full Text] [Related]
10. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K
Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657
[TBL] [Abstract][Full Text] [Related]
11. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study.
Roehrborn CG; Siami P; Barkin J; Damião R; Major-Walker K; Morrill B; Montorsi F;
J Urol; 2008 Feb; 179(2):616-21; discussion 621. PubMed ID: 18082216
[TBL] [Abstract][Full Text] [Related]
12. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L
J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive assessment of prostatic obstruction in elderly men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
van Venrooij GE; Eckhardt MD; Boon TA
Urology; 2004 Mar; 63(3):476-80. PubMed ID: 15028441
[TBL] [Abstract][Full Text] [Related]
14. Acute urinary retention: medical management and the identification of risk factors for prevention.
Khastgir J; Khan A; Speakman M
Nat Clin Pract Urol; 2007 Aug; 4(8):422-31. PubMed ID: 17673913
[TBL] [Abstract][Full Text] [Related]
15. Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.
Kristal AR; Arnold KB; Schenk JM; Neuhouser ML; Weiss N; Goodman P; Antvelink CM; Penson DF; Thompson IM
J Urol; 2007 Apr; 177(4):1395-400; quiz 1591. PubMed ID: 17382740
[TBL] [Abstract][Full Text] [Related]
16. The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction.
Thomas AW; Cannon A; Bartlett E; Ellis-Jones J; Abrams P
J Urol; 2005 Nov; 174(5):1887-91. PubMed ID: 16217330
[TBL] [Abstract][Full Text] [Related]
17. Review of exercise and the risk of benign prostatic hyperplasia.
Sea J; Poon KS; McVary KT
Phys Sportsmed; 2009 Dec; 37(4):75-83. PubMed ID: 20048544
[TBL] [Abstract][Full Text] [Related]
18. Concordance rates and modifiable risk factors for lower urinary tract symptoms in twins.
Rohrmann S; Fallin MD; Page WF; Reed T; Partin AW; Walsh PC; Platz EA
Epidemiology; 2006 Jul; 17(4):419-27. PubMed ID: 16699472
[TBL] [Abstract][Full Text] [Related]
19. Lower urinary tract symptoms and depressive symptoms in elderly men.
Wong SY; Hong A; Leung J; Kwok T; Leung PC; Woo J
J Affect Disord; 2006 Nov; 96(1-2):83-8. PubMed ID: 16815555
[TBL] [Abstract][Full Text] [Related]
20. [Arteriosclerotic risk factors and benign prostatic hyperplasia].
Shen W; Yao HQ; Deng ZX; Zhang XM; Zhang LC; Hu WL
Zhonghua Nan Ke Xue; 2010 Jan; 16(1):29-33. PubMed ID: 20180401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
